You will be redirected to:

Continue
Logo - Kls
Logo - Kls
  • Playbook
  • Services
    Services
    Delivery models
  • Insights
  • Technology
  • Careers
  • About us
    Company purpose
    Life science innovation
    Committed Keyrus
    Regulatory compliance
    Investors
    Management team
    Keyrus Group
    Locations

Press release

EvidentIQ and Keyrus Life Science are building a strategic partnership leveraging best-in-class technologies, data science and clinical research expertise to digitally streamline clinical trials.

Paris 9th January, 2023 (France) - Today, EvidentIQ, a leading clinical data science group and Keyrus Life Science, the international Connected Contract Research Organization (C²RO), announced the signing of a strategic partnership. The synergy between both companies will improve automation, efficiency and agility in clinical research by leveraging new eClinical capabilities.

EvidentIQ, based in Hamburg, is a leading clinical data science group, offering state-of-the art eClinical solutions (eConsent, EDC, CTMS, eCOA, RWE).

Keyrus Life Science, operating across Europe and North America, connects CRO expertise, life data science and digital enablement to fully leverage both clinical research ecosystems and real-world evidence to help organizations shape better their clinical research trial strategies.

“I’m very proud to be able to announce today the formation of a strategic partnership between EvidentIQ and Keyrus Life Science. I strongly believe that it will transform the industry and create significant value for our customers as they will benefit from receiving industry leading eClinical technology, Real World Evidence and a world-class, full service model on one hand.” says Andreas Weber, CEO at EvidentIQ.

“Thanks to this partnership, Keyrus Life Science and EvidentIQ will be able to digitally empower and operate clinical research on a new level, offering life science companies the capability to access enhanced reactivity, flexibility and get the full value from their data in the development of new drugs and therapies” states Michael Attlan, VP Life Science at Keyrus, “This synergy and the complementary offerings between our two companies are both key success factors in delivering practical and efficient solutions for our clients in clinical research”.

whatsapptwitter
linkedinfacebookworkplace
newsletter.svg

Never miss an insight

Stay updated on the latest articles, events, and more

Your email address is only used to send you the Keyrus newsletter and for commercial prospecting purposes. You can use the link in our emails to opt-out at any time. Learn more about the management of your data and your rights.

Continue reading

Blog post

Introduction to a Clinical Data Fabric

January 12, 2023

Nowadays, all companies active in the life science ecosystem consider data as a crucial asset to their success. Pharma companies are collecting more and more information during their clinical trials or commercial and medical activities. Clinical laboratories have to deploy complex data infrastructures to better serve their patients and clients, and Biotech and MedTech companies need to gather and analyze a lot of scientific and technical data.

Press release

Keyrus Life Science and Parean Biotechnologies announce their alliance to accelerate innovation in biometry, bioinformatics and biostatistics, in the EU and North America.

November 10, 2022

Paris, Levallois-Perret, November 7th, 2022 - Keyrus Life Science and Parean Biotechnologies will join their expertise in data science and technologies to meet the most critical challenges for clients in the fields of biometry, biostatistics and bioinformatics.

Event

Wrap up of our summer 2022 North American conferences

September 21, 2022

This summer was very busy and interesting for the Keyrus Life Science North America Team. We attended three pivotal life science conferences: Decentralized Clinical Trials Conference, BIO International Convention, and DIA Conference.

Press release

Keyrus Life Science, the Connected-CRO (C2RO), strengthens its synergies with the Keyrus Group, adopting a new visual identity and deploying a complete portfolio of services to drive clinical research forward.

June 27, 2022

Paris, Levallois-Perret, June 23, 2022 - Keyrus Life Science announces the launch of its new visual identity strengthening its synergies with the Keyrus Group to address the most pressing challenges of its clients in the life science industry and to drive clinical research forward.

Expert's opinion

Future of CRO & Digitalization

June 23, 2022

Digitalization, data and connectivity has become part of our daily lives in all its dimensions.

Expert's opinion

How digitalization improves clinical data management practice

June 17, 2022

Clinical trials produce a massive amount of data. In most cases, the challenge lies less in the volume of data to process, but more in its diversity. The sources of data are indeed numerous and do not stop increasing.

Blog post

World Heart Day

April 28, 2022

The World Heart Day, an occasion to remind us all, that cardiovascular diseases (CVD) causes more than 18 million of deaths per year.  

Event

World Alzheimer’s Day

April 28, 2022

Today, September 21st, is the World Alzheimer’s Day, so let’s do a quick review of the investigated therapeutic targets to find a cure to this pathology

Event

Team Building - Action Again Hunger

April 28, 2022

Keyrus Life Science joined the Keyrus Foundation in the team sports challenge 'Connected against hunger'

Blog post

ECCRT and KEYRUS LIFE SCIENCE enter into an agreement for online training for all Keyrus staff members.

April 28, 2022

We are happy to have partnered with European Centre for Clinical Research Training (ECCRT) in training our experts at Keyrus Life Science.

Logo - Kls
Headquarters

155 rue Anatole France 92593 Levallois-Perret

Phone:+33 (0)1 41 34 10 00

Fax:+33 (0)1 41 34 10 10

LinkedInKlsInstagram
PlaybookServicesInsightsTechnologyCareersAbout us
Company purposeLife science innovationCommitted KeyrusRegulatory complianceInvestorsManagement teamKeyrus GroupLocations
Legal notice & Terms of use
Privacy policy
Data protection